Published on in Vol 1, No 1 (2020): Jan-Dec
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/19583, first published
.
Journals
- Shende P, Khanolkar B, Gaud R. Drug repurposing: new strategies for addressing COVID-19 outbreak. Expert Review of Anti-infective Therapy 2021;19(6):689 View
- Ofori S, Hung Y, Schwind J, Diallo K, Babatunde D, Nwaobi S, Hua X, Sullivan K, Cowling B, Chowell G, Fung I. Economic evaluations of interventions against influenza at workplaces: systematic review. Occupational Medicine 2022;72(2):70 View
- Varghese R, Digholkar G, Karsiya J, Salvi S, Shah J, Kumar D, Sharma R. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug Metabolism and Personalized Therapy 2023 View
- Varghese R, Digholkar G, Karsiya J, Salvi S, Shah J, Kumar D, Sharma R. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug Metabolism and Personalized Therapy 2024;38(4):295 View
- Nakamura S, Sato Y, Kobayashi T, Oya A, Fujie A, Matsumoto M, Nakamura M, Kanaji A, Miyamoto T. Bezafibrate attenuates immobilization-induced muscle atrophy in mice. Scientific Reports 2024;14(1) View